Will Insurance or a Government Scheme — Pay for Gefitinib?
Several schemes and programmes can reduce what you pay for gefitinib. Whether any of them apply to you depends on your income, your state of residence, your insurer's policy terms, and which hospital is treating you.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed August 2026
- Government schemes exist — Ayushman Bharat and state-level schemes in Telangana and Andhra Pradesh cover cancer treatment at empanelled hospitals.
- Private insurance has gaps — Most standard health policies cover hospitalisation. Oral medicines taken at home, like gefitinib, often fall outside standard cover.
- Manufacturer assistance is available — The companies that make gefitinib — branded and generic — sometimes offer assistance programmes. Your treating team can tell you which currently apply.
- Generic versions cost far less — Government-approved generic gefitinib is available in India at a fraction of the branded price, including through Jan Aushadhi stores.
on Panel
Survival Rate*
Treated
(800+ reviews)
Several government schemes and private insurance policies can offset the cost of gefitinib. Ayushman Bharat – PMJAY covers cancer treatment at empanelled centres. State schemes in Telangana and Andhra Pradesh add further support. Manufacturer assistance programmes and approved generic versions can also reduce out-of-pocket costs. Your eligibility depends on income, ration card status, and your insurer's policy terms.
Which schemes and programmes exist for cancer medicine costs in India?
- Ayushman Bharat – PMJAY
- The central government health assurance scheme for economically weaker sections. Covers a defined set of cancer treatments at government-empanelled hospitals. Eligibility is based on the Socio-Economic and Caste Census list, or a state-issued Ayushman card.
- Aarogyasri (Telangana)
- The Telangana state government scheme for families holding a white or pink ration card. Covers defined cancer procedures at empanelled hospitals in the state.
- YSR Aarogyasri (Andhra Pradesh)
- The Andhra Pradesh government scheme covering cancer treatment for eligible families at empanelled hospitals. Structure and eligibility are similar to Aarogyasri.
- Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)
- A central government programme running Jan Aushadhi stores that sell approved generic medicines — including generic gefitinib — at significantly reduced prices compared to the branded product.
- Manufacturer patient assistance programme
- The companies that make branded and generic gefitinib sometimes offer programmes to reduce or waive costs for patients who cannot afford treatment. Your treating oncologist or the hospital social worker can check which programmes are currently open.
- Private insurance with OPD or cancer rider
- Some private policies include an outpatient or cancer-specific rider that covers oral targeted therapies taken at home. Standard hospitalisation-only policies generally do not cover this category of medicine.
What should you check before assuming you are covered?
- Ask whether your family has an Ayushman Bharat card or is on the SECC list — your local government health office or treating hospital can verify this.
- If you are in Telangana, confirm whether your ration card (white or pink) makes you eligible for Aarogyasri at an empanelled hospital.
- If you are in Andhra Pradesh, check your eligibility for YSR Aarogyasri at your treating hospital's insurance desk.
- Read your private insurance policy document — search for the words 'outpatient', 'OPD', 'oral chemotherapy', or 'cancer rider' to see if oral medicines are included.
- Ask your oncology team or the hospital's medical social worker whether a manufacturer assistance programme is currently available for gefitinib.
- Ask your pharmacist about the nearest Jan Aushadhi store if cost is a barrier — generic gefitinib is stocked at many such stores.
Why does standard private insurance often not cover gefitinib?
Most private health insurance policies in India are built around hospitalisation: room charges, surgeon fees, diagnostics, and medicines given during an inpatient stay.
Gefitinib is a tablet you take at home every day. Because it is dispensed as an outpatient medicine rather than given during a hospital admission, it falls outside the scope of many standard policies.
Some insurers offer an optional rider — sometimes called an OPD cover, oral chemotherapy benefit, or cancer-specific add-on — that does cover medicines like gefitinib. If your policy was taken out in the last few years, check the policy schedule carefully or call your insurer directly to ask.
If your current policy does not cover oral cancer medicines, ask your insurer whether a rider can be added at the next renewal.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
How do government schemes apply to an oral medicine taken at home?
Government schemes such as Ayushman Bharat and Aarogyasri were designed around hospital packages — defined procedures, surgeries, and inpatient stays. Oral targeted therapies sit in a grey area that varies by scheme version and empanelled hospital.
In practice, some empanelled hospitals can dispense covered medicines through their own pharmacy as part of a treatment package. Others cannot. This depends on how the hospital is registered with the scheme and which packages have been approved.
The most direct way to find out is to ask the insurance or billing desk at your treating hospital — not the scheme's general helpline. They handle these questions every day and will know what is actually claimable at that specific centre.
If the scheme does not cover the medicine directly, it may still cover your consultations, EGFR mutation testing, and monitoring scans — all of which are part of your care.
Did you know?
India has some of the most competitively priced generic oncology medicines in the world. Generic gefitinib manufactured by Indian companies has received regulatory approval and is available through Jan Aushadhi stores and registered oncology pharmacies.
For families without insurance or scheme coverage, asking specifically for the generic version — rather than the branded product — can make a material difference to monthly out-of-pocket costs.
Source: Pradhan Mantri Bhartiya Janaushadhi Pariyojana, Ministry of Chemicals and Fertilizers, Government of India
What else should you know about paying for gefitinib?
What if no scheme or insurance covers me at all?
Generic gefitinib is the most reliable fallback. Ask your oncologist to prescribe the generic version rather than the branded product, and ask where the nearest Jan Aushadhi store is. Some hospital pharmacies also stock generic versions at lower prices. The hospital social worker — most oncology centres have one — can also point you towards state-level cancer welfare funds and NGO support programmes that are not widely advertised.
Does PMJAY cover the full course of gefitinib, or only the start?
PMJAY covers defined treatment packages rather than open-ended prescriptions. Whether ongoing oral medication is included depends on the package code under which your treatment is registered. Your hospital's PMJAY desk will be able to tell you which package applies to your diagnosis and what it covers. If the package runs out, the hospital social worker can sometimes help identify supplementary support from state or charitable sources.
How do I find out if the manufacturer has an assistance programme?
Manufacturer assistance programmes open and close, and their terms change. The most reliable way to check is to ask your treating oncologist or the oncology pharmacist at your hospital. They are often the first to know when a programme is available because pharmaceutical company representatives inform them directly. A general internet search is less reliable because programme details are frequently out of date by the time a page is indexed.
My hospital is not empanelled under PMJAY. Can I still use my card elsewhere?
Yes. PMJAY and state scheme cards are not tied to a single hospital. You can transfer your care to an empanelled hospital that accepts the scheme. Your treating oncologist can provide a referral, or you can search the official Ayushman Bharat hospital empanelment list — your current hospital's insurance desk or your district health office can help you locate the nearest empanelled centre that treats lung cancer.
Can I combine a government scheme with private insurance?
In principle, yes — one can cover what the other does not, provided both are declared and the claims are for different components of care. In practice, coordinating between a government scheme and a private insurer requires careful paperwork and both must be informed upfront. The hospital billing desk will know how to handle this for your specific situation, as the rules vary by insurer and by the scheme version in your state.
Is the EGFR mutation test itself covered by insurance or schemes?
EGFR mutation testing is a diagnostic test and is sometimes covered under insurance policies that include diagnostics, or within the package cost of certain scheme procedures. It is worth asking specifically about this test when you check your coverage, because it is a prerequisite for being prescribed gefitinib and the cost can be significant if paid out of pocket. Ask your oncologist which test format — tissue or liquid biopsy — is required for your situation, so you claim for the right test.
Explore 75 more Lung Cancer Targeted Medicines topics
Drug Deep Dive: Gefitinib (Iressa)
- Diarrhoea on Gefitinib: Home Management and Warning Signs
- Diet and Nutrition While on Gefitinib
- Fertility, Pregnancy and Contraception on Gefitinib
- Gefitinib (Iressa, Geftinat, Geftib): The Complete Patient Guide
- Gefitinib Myths: 'It's Only for Poor Patients' and Other Half-Truths
- Gefitinib Plus Chemotherapy: Does Adding Chemo Actually Help?
- Gefitinib Price in India: Brand, Generic and Monthly Cost
- Gefitinib Rash: Why It Appears in Week Two and How to Treat It
- Gefitinib Side Effects: The Complete List and Timeline
- Gefitinib Success Rate and Survival: An Honest Look at the Numbers
- Gefitinib and Antacids: The Interaction That Silently Reduces Absorption
- Gefitinib in Early-Stage vs Advanced Lung Cancer: Different Goals
- Gefitinib in Elderly Patients and Those With Other Illnesses
- Gefitinib vs Osimertinib: Making the Decision When Cost Matters
- How Does Gefitinib Work? The First-Generation EGFR Inhibitor Explained
- How Long Does Gefitinib Take to Work?
- How Long Will You Stay on Gefitinib?
- Raised Liver Enzymes on Gefitinib: What Your LFT Report Means
- T790M Testing After Gefitinib Stops Working: The Next Step Explained
- Taking Gefitinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Gefitinib
- When Gefitinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Gefitinib? EGFR-Mutant Lung Cancer
- Will Insurance or a Government Scheme Pay for Gefitinib?
- Work, Travel and Daily Life on Gefitinib
Drug Deep Dive: Alectinib (Alecensa)
- Alectinib (Alecensa, Alectinib): The Complete Patient Guide
- Alectinib After Surgery for Early-Stage ALK-Positive Lung Cancer
- Alectinib Myths: Is ALK-Positive Cancer 'Curable'?
- Alectinib Price in India: Brand, Generic and Monthly Cost
- Alectinib Side Effects: The Complete List and Timeline
- Alectinib Success Rate and Survival: An Honest Look at the Numbers
- Alectinib and Brain Metastases: How It Protects the Brain
- Alectinib in Elderly Patients and Those With Other Illnesses
- Alectinib vs Crizotinib vs Lorlatinib: Choosing an ALK Inhibitor
- Diet and Nutrition While on Alectinib
- Do You Need Chemotherapy Alongside Alectinib?
- Drug, Food and Supplement Interactions With Alectinib
- Fertility, Pregnancy and Contraception on Alectinib
- How Does Alectinib Work? The Second-Generation ALK Inhibitor Explained
- How Long Does Alectinib Take to Work?
- How Long Will You Stay on Alectinib?
- Muscle Pain and High CPK on Alectinib: When to Worry
- Severe Sun Sensitivity on Alectinib: Preventing Serious Burns
- Taking Alectinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Alectinib
- Weight Gain, Constipation and a Slow Pulse on Alectinib
- When Alectinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Alectinib? ALK-Positive Lung Cancer
- Will Insurance or a Government Scheme Pay for Alectinib?
- Work, Travel and Daily Life on Alectinib
Drug Deep Dive: Osimertinib (Tagrisso)
- Adjuvant Osimertinib After Lung Cancer Surgery: Three Years of Tablets
- Breathlessness or New Cough on Osimertinib: Recognising Lung Injury (ILD)
- Diet and Nutrition While on Osimertinib
- Drug, Food and Supplement Interactions With Osimertinib
- Fertility, Pregnancy and Contraception on Osimertinib
- Heart Rhythm and Ejection Fraction Changes on Osimertinib
- How Does Osimertinib Work? The Third-Generation EGFR Inhibitor Explained
- How Long Does Osimertinib Take to Work?
- How Long Will You Stay on Osimertinib?
- Osimertinib (Tagrisso): The Complete Patient Guide
- Osimertinib Myths: Clear Scans, Stopping Early and Generic Quality
- Osimertinib Price in India: Brand, Generic and Monthly Cost
- Osimertinib Side Effects: The Complete List and Timeline
- Osimertinib Success Rate and Survival: An Honest Look at the Numbers
- Osimertinib With Chemotherapy: Who Actually Benefits From the Combination?
- Osimertinib and Brain Metastases: Why It Works Inside the Brain
- Osimertinib in Elderly Patients and Those With Other Illnesses
- Osimertinib vs Gefitinib and Erlotinib: Is the Costlier Drug Worth It?
- Rash, Dry Skin and Nail Problems on Osimertinib
- Taking Osimertinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Osimertinib
- When Osimertinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Osimertinib? EGFR-Mutant Lung Cancer
- Will Insurance or a Government Scheme Pay for Osimertinib?
- Work, Travel and Daily Life on Osimertinib
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Frequently asked questions
Does Ayushman Bharat cover gefitinib?
Ayushman Bharat – PMJAY covers defined cancer treatment packages at empanelled hospitals, which may include some costs associated with starting targeted therapy. Whether it covers the ongoing oral medicine itself depends on the hospital's package registration and the specific package code assigned to your treatment. The most accurate answer comes from the PMJAY help desk at your treating hospital, not from the scheme's general helpline, because coverage is package-specific and varies by centre.
What is the cost of gefitinib in India?
The branded version and the generic versions are priced differently, and prices change with government price control notifications issued by the NPPA under the DPCO. Rather than quoting a figure that may already be outdated, ask your pharmacist for the current maximum retail price — it is printed on the pack — and ask specifically for the generic version if cost is a concern. Jan Aushadhi stores typically offer the lowest available price for approved generics.
Which state schemes cover cancer treatment in Telangana and Andhra Pradesh?
Telangana operates the Aarogyasri scheme, and Andhra Pradesh operates YSR Aarogyasri. Both cover cancer treatment for eligible families — generally those with white or pink ration cards — at hospitals empanelled under the respective scheme. The scope of cancer cover, including which procedures and medicines fall within the packages, varies by scheme version. The insurance desk at your treating hospital will confirm eligibility and the current package scope for your specific diagnosis.
Will my private insurance pay for an oral cancer medicine?
It depends on your policy. Standard hospitalisation-only policies in India generally do not cover oral medicines taken at home. Some policies include an OPD rider, oral chemotherapy benefit, or cancer-specific add-on that does. Check your policy schedule for the words 'outpatient', 'OPD', or 'oral chemotherapy'. If you are unsure, call your insurer and ask directly whether a daily oral cancer medicine prescribed by your oncologist would be reimbursed under your current cover.
Are there NGOs or charitable trusts that help pay for cancer medicines?
Yes. Several NGOs and charitable trusts in India provide financial support for cancer medicines, including oral targeted therapies. Your hospital's oncology social worker is the best first point of contact — most large oncology centres have one, and they maintain current lists of active programmes. Support available through NGOs changes frequently, so the social worker's up-to-date knowledge is more reliable than a list published online, which may not reflect what is currently active.
Does having a cancer diagnosis affect future insurance eligibility?
A cancer diagnosis is a material fact that must be disclosed when applying for new insurance in India. Failing to disclose it can invalidate a future claim. Most insurers will not issue a new standard policy during active cancer treatment, though some offer cancer-specific policies or top-up covers. If you already hold a policy, your existing coverage generally continues as long as premiums are paid. Talk to your insurer or an independent adviser before making any changes to your current cover.